Glaucoma Reports

2018 Glaucoma Surgical Device Report: A Global Market Analysis for 2017 to 2023

Our report on the glaucoma surgical device market is in its eleventh edition. It is a leading industry source for accurate and relevant information on all aspects of the glaucoma surgical device market. We cover prevalence and forecasts for glaucoma worldwide, and we discuss the ophthalmologists who treat glaucoma. We examine the role of surgical intervention, the market dynamics for currently commercialized products, and the pipeline of investigational devices that may offer improved outcomes. We forecast product demand in units and dollars, and we analyze market shares by product category. We also discuss key strategic issues.

Additional DescriptionMore Details


What's New?
In the 2018 report:
• We simplify the glaucoma surgical product categories to four: minimally invasive glaucoma surgery (MIGS), trab plus, tubes, and canal surgery devices.
• We look at the percentage of MIGS devices being implanted In the US by cataract surgeons, glaucoma specialists, and general ophthalmologists.
• We identify the MIGS stents in the pipeline that will drive penetration in each of the stages of glaucoma: mild, moderate, advanced, and severe.
• We update the global glaucoma populations by primary open-angle glaucoma, primary angle-closure glaucoma, secondary and pediatric glaucomas, and ocular hypertension in our eight categories.
• We analyze the degree to which saturation of diagnosed glaucoma patients will take place in our eight regional or economic categories over the next five years, given our aggressive MIGS forecast.

Market Scope’s 2018 Glaucoma Surgical Device Report: A Global Market Analysis for 2017 to 2023 provides in-depth coverage of current and future surgical devices for treating glaucoma.


Four Categories Are Analyzed In This Report:

Conventional Glaucoma Surgery (CGS) Devices, Advanced Technology Glaucoma Surgery (ATGS) Devices, Selective Trabeculoplasty (SLT) Lasers, and Disposables/Instruments


Each Market Segment Includes:


An Analysis of Market Competitors and Five‐Year Forecasts for Market Performance

Also Included in This Report:
• Background on Glaucoma and its Forms
• The Global Glaucoma Populations
• Glaucoma Care Providers
• Diagnosing Glaucoma
• Treating Glaucoma
• Investigational Devices in the Pipeline
• 34 Company Profiles
• 78 Color Tables and 55 Color Figures

The data included in our reports is based on surveys of ophthalmologists, reviews of clinical data, interviews with company executives, and analysis of company financial data.

This edition of our 2018 Glaucoma Surgical Device Report: A Global Market Analysis for 2017 to 2023 was released in August 2018. The report is printed in color and spiral bound for easy reading. Two licensing types are available for this report. The price of the report is $6,500 for a SINGLE USER LICENSE (an electronic PDF copy and/or an additional paper copy is available for use within your company for an additional $500 and $300, respectively). The price of the ENTERPRISE LICENSE is $9,750 (includes a printable PDF and supplemental Excel file with all the tables and figures in the report).

*Note: The PDFs are not downloadable: PDF copies of reports are manually prepared and emailed to the account listed on the order within 24 hours. Please call our office for immediate assistance or to discuss purchasing additional copies of a report at (314) 835-0600.


Market Scope’s industry reports are meticulously prepared by a dedicated team of in-house consultants/analysts with over 100 years of collective ophthalmic experience and each data point is driven by a combination of sources, including the following:


• Our proprietary global disease population and demographic models
• Twenty years and counting of ophthalmologist survey data
• Analysis of company published financial reports
• Focused coverage of ophthalmic scientific research, business news and other activities
• Attendance and participation in major, worldwide ophthalmic meetings
• Interviews and long-standing relationships with company executives and practicing ophthalmologists

Product Options

Price: from $6,500.00

Loading Updating cart...

2018 Glaucoma Pharmaceuticals Report: A Global Market Analysis for 2017 to 2023

Our report on the glaucoma pharmaceuticals market, now in its fifth edition, is a leading industry source for accurate and relevant information on all aspects of the glaucoma pharmaceuticals market. The glaucoma pharmaceuticals market is one of the largest and most complex market segments in ophthalmology with a variety of drug classes, as well as proprietary and generic versions of many drugs. Current ocular hypotensive medication classes used to treat glaucoma were developed 20 years ago or more, and generic versions of these medications are now in widespread use.

Additional DescriptionMore Details

Market Scope’s 2018 Glaucoma Pharmaceutical report features:

• New and updated estimates of glaucoma populations around the world
• Analysis of two new classes glaucoma therapeutics launched in the US in 2018: nitric oxide-donating compounds and rho kinase (ROCK) inhibitors
• Expanded discussions of genetics, gene therapies, stem cell therapies, and sustained-release devices

The report analyses 61 marketed medications and differences in their popularity around the world, 16 pipeline agents in development, 22 discontinued drug candidates, 10 clinical stage alternative drug delivery platforms, 10 preclinical alternative drug delivery platform programs, and another nine university-based drug delivery research programs.

It includes new market forecasts based on updated information from user surveys and price surveys.

ABOUT THE AUTHOR


Four Disease Categories Are Analyzed In This Report:


Primary Open-angle Glaucoma (POAG), Primary Angle-closure Glaucoma (PACG), Other Secondary OAG and ACG, and Ocular Hypertension (OHT)

Each Market Segment Includes:
An Analysis of Market Competitors and Five‐Year Forecasts for Market Performance

Also Included in This Report:
• Overview of Glaucoma
• Prevalence of Glaucoma and Diagnosed Cases
• Glaucoma Care Providers
• Diagnosing Glaucoma
• Treating Glaucoma
• Glaucoma Medications in the Marketplace
• Development Pipeline for Glaucoma Rx
• Adjunctive Drugs Used in Glaucoma Surgery
• 25 Company Profiles
• 54 Color Tables and 33 Color Figures

This edition of our 2018 Glaucoma Pharmaceutical Report was published in June 2018. The report is printed in color and spiral bound for easy reading. Two licensing types are available for this report. The price of the report is $6,800 for a SINGLE USER LICENSE (an electronic PDF copy and/or an additional paper copy is available for use within your company for an additional $500 and $300, respectively). The price of the ENTERPRISE LICENSE is $10,200 (includes a printable PDF and supplemental Excel file with all the tables and figures in the report).

*Note: The PDFs are not downloadable: PDF copies of reports are manually prepared and emailed to the account listed on the order within 24 hours. Please call our office for immediate assistance or to discuss purchasing additional copies of a report at (314) 835-0600.

Market Scope’s industry reports are meticulously prepared by a dedicated team of in-house consultants/analysts with over 100 years of collective ophthalmic experience and each data point is driven by a combination of sources, including the following:

• Our proprietary global disease population and demographic models
• Twenty years and counting of ophthalmologist survey data
• Analysis of company published financial reports
• Focused coverage of ophthalmic scientific research, business news and other activities
• Attendance and participation in major, worldwide ophthalmic meetings
• Interviews and long-standing relationships with company executives and practicing ophthalmologists

Product Options

Price: from $6,800.00

Loading Updating cart...

2017 Ophthalmic Laser Report: A Global Market Analysis for 2016 to 2022 (Photocoagulation, Photodisruption, and SLT

Our report on the ophthalmic laser market is in its seventh edition. It is a leading industry source for accurate and relevant information on all aspects of the market. The report discusses the epidemiology of retinal diseases, glaucoma, and cataracts, plus other diseases and disorders that require laser intervention. The report covers photocoagulation, photodisruption, and SLT lasers. It excludes excimer and femtosecond lasers. We forecast product demand in units and dollars, and we analyze market shares by product category.

Additional DescriptionMore Details

We analyze worldwide markets using the following geographic/economic categories: the US, Western Europe, Japan, Other Wealthy Nations, China, India, Latin America, and Rest of World. This report includes market data for 2016, and we forecast market performance through 2022.

ABOUT THE AUTHOR

Our report is organized into key areas and includes:

• Review of Global Retinal Diseases and Treatment Methods
• Review of Global Glaucoma and Treatment Methods
• Review of Global Cataracts and Treatment Methods
• Global Overview of Ophthalmologists
• Forecast of Photocoagulation Lasers by Region
• Forecast of Photodisruption Lasers by Region
• Forecast of SLT Lasers by Region
• 13 Company Profiles
• 50 Color Tables and 22 Color Figures

2017 Laser Report Graphic

The data included in our reports is based on surveys of ophthalmologists, reviews of clinical data, interviews with company executives, published medical reviews, and analysis of company financial data.

VIEW THE TABLE OF CONTENTS OF THIS REPORT

This edition of our Ophthalmic Laser Report: A Global Market Analysis for 2016 to 2022 was released in June 2017. The report is printed in color and spiral bound for easy reading. Two licensing types are available for this report. The price of the report is $4,000 for a SINGLE USER LICENSE (an electronic PDF copy and/or an additional paper copy is available for use within your company for an additional $500 and $300, respectively). The price of the ENTERPRISE LICENSE is $6,000 (includes a printable PDF and supplemental Excel file with all the tables and figures in the report).

*Note: The PDFs are not downloadable: PDF copies of reports are manually prepared and emailed to the account listed on the order within 24 hours. Please call our office for immediate assistance or to discuss purchasing additional copies of a report at (314) 835-0600.

Market Scope’s industry reports are meticulously prepared by a dedicated team of in-house consultants/analysts with over 100 years of collective ophthalmic experience and each data point is driven by a combination of sources, including the following:

• Our proprietary global disease population and demographic models
• Twenty years and counting of ophthalmologist survey data
• Analysis of company published financial reports
• Focused coverage of ophthalmic scientific research, business news and other activities
• Attendance and participation in major, worldwide ophthalmic meetings
• Interviews and long-standing relationships with company executives and practicing ophthalmologists

Product Options

Price: from $4,000.00

Loading Updating cart...

US Glaucoma Market Quarterly Updates

Our US Glaucoma Market Quarterly Updates are designed to keep you up to date with data gathered four times per year on the surgical options and medications being used to treat glaucoma patients. We began this survey process in 2012. These updates are designed to improve your decision-making process with accurate and timely information on a variety of vital practice of medicine issues, doctors’ evaluations of pharmaceuticals and surgical equipment, and the identification of significant trends in the marketplace for the treatment of glaucoma.

Additional DescriptionMore Details

Our updates include trend analysis based on comparisons with information gathered previously. All information is presented in color charts and tables with concise narratives for enhanced clarity and context.

We measure and analyze key metrics of the US glaucoma treatments market, including the following topics:

• Glaucoma Treatment Regimen
• Patient Medication Usage
• Medication Compliance
• Glaucoma Tube Shunts
• Glaucoma Drainage Devices
• Other Glaucoma Devices and Treatments
• Glaucoma Volume and Surgery Location
• Laser Trabeculoplasty
• Interest Level in Investigational Glaucoma Treatments

Glaucoma Surgical Procedures

We also provide a full-year forecast for US glaucoma procedures and a comparison with volumes during the prior year. The survey has been developed in conjunction with glaucoma specialists and industry manufacturers.

US Glaucoma Quarterly Market Updates are published each quarter. We have been conducting surveys of ophthalmologists in various subspecialties for 12 years, and our analyses of survey data are used by hundreds of ophthalmological practices and businesses in the ophthalmic industry.

*Note: The PDFs are not downloadable: PDF copies of reports are manually prepared and emailed to the account listed on the order within 24 hours. Please call our office for immediate assistance or to discuss purchasing additional copies of a report at (314) 835-0600.

VIEW THE TABLE OF CONTENTS FOR THIS REPORT

Product Options

Price: from $3,500.00

Loading Updating cart...
LoadingUpdating...

Shopping Cart

Your shopping cart is empty
View all of the reports

Note: Report PDFs are not downloadable

PDF copies of reports are manually prepared and emailed to the account listed on the order within 24 hours. Please call our office for immediate assistance or to discuss purchasing additional copies of a report at (314) 835-0600.